Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Richard Blumberg
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Syntalogic
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Partners HealthCare Committee on Outside Activities (COA) Research Review Panel reviewed Dr. Richard Blumberg’s financial interest in Syntalogic in connection with this R01 grant entitled, “Regulation of Mucosal Lymphocytes”. The research’s main objective is to assess the role of CEACAM1 in IBD.
Dr. Blumberg is a co-founder and co-owner of Syntalogic, a small start-up company that is engaged in the research and development of diagnostics and therapeutics in the field of immuno-oncology. Specifically, the company seeks to develop therapeutics that block CEACAM1 and the interaction of CEACAM1 with other molecules (e.g., TIM3, PD1). Syntalogic is focused on developing these therapeutics for certain cancers.
The COA reviewers noted that IP developed under this grant has been licensed to Syntalogic. They believe that the research could further inform and, to some extent, further validate Syntalogic’s research/development program. While the research under the grant is focused on animal models, the reviewers nonetheless thought that results found in animal models could have some relevance for the development of human therapies.
Regulation of Mucosal Lymphocytes
PROJECT NARRATIVE The proposed research is relevant to public health because immune tolerance in mucosal tissues is of central importance to whether or not inflammatory bowel disease (IBD) develops making it important to define how specific molecules such as carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) and T-cell immunoglobulin mucin domain 3 (TIM-3) functions in these processes. The proposed studies are relevant to the mission of the NIDDK because they are expected to identify several new therapeutic strategies for inhibiting inflammation associated with IBD or potentially enhancing immunity in the treatment of cancers and infections.
Filed on August 01, 2016.
Tell us what you know about Richard Blumberg's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Richard Blumberg filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Richard Blumberg | Brigham and Women's Hospital | Conflict of Interest | Syntimmune, Inc. | $60,000 - $79,999 |
| Richard Blumberg | Brigham and Women's Hospital | Conflict of Interest | Syntimmune, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.